Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report

Fig. 1

Schematic disease progression. a Primary tumor at diagnosis. The patient was diagnosed with lung cancer on the left lower lobe at the stage IIIa (pT2N2M0). The excised tumors from thorocoscopic lobectomy were confirmed as invasive ADC (20% of the total tumor) and SC (80% of the total tumor) morphologically, and were further sliced to separate ADC and SC sections for targeted NGS analysis. b Progressive increase of soft tissue masses in the anterior mediastinum, which is confirmed as SC by biopsy

Back to article page